Cost and Limitations

Our pricing is simple and easy to understand, there are no hidden costs

We have a one time licensing fee and a monthly on going support fee. Optional costs for integrated electronic claim filing and patient notification are paid directly to our partners, eyefinity and Apex EDI for claim filing and Vision software for automated patient notification. In order to meet meaningful use objectives for e-prescribing and direct messaging there are additional per provider fees for these features (see pricing structure below)

One time licensing fee: $7,995.00

  • Permanent use of the software ***
  • Training for all Doctors and Staff
  • Configuration of your database
  • Your practice configuration
  • ***Must stay current on monthly subscription

Monthly subscription / support fee:

$199.00 for the first provider / $100.00 for each additional provider

  • Access to Cyclops EHR for Doctors and staff
  • Data storage, back up and usage
  • Unlimited workstations
  • Unlimited access to our Customer Support
  • All standard features and updates

Cost and Limitations

This certified product (Cyclops version 4) may require ongoing monthly cost to support the following:

  • Secure Messaging service (170.314.e.3) fee: $25.00 per provider
  • Electronic prescribing(170.314.b.3) fee: $50.00 per provider
  • Unlimited workstations
  • Unlimited access to our Customer Support
  • All standard features and updates

Contractual Limitations

There are no contractual obligations

Termination and Data Extraction fees may apply.

This certified product (Cyclops version 4) may require one-time cost to establish interfaces for the following:

  • Secure Messaging service (170.314.e.3) fee: $100.00 per provider

Optional Services fees

  • Eyefinity and ApexEDI electronic claim filing
  • Vision software patient notification fees for the above mentioned services vary by plan and are paid directly to the entities listed above, the fees are not associated with the use of Cyclops Eyecare Records.

If you choose to opt for these services, it is required to contact these entities and initiate an account directly with them.

ONC Certified

“Cyclops Eye Care Records, which met the requirements for stage 2 Meaningful use as a complete EHR is a comprehensive software for Eye Care providers which includes Electronic Medical records, practice management, inventory control, Electronic Insurance claims, direct messaging, e-prescribing, a complete patient automated notification system and many more features that run the Eye Care practice day to day activities.”

The Office of the National Coordinator (ONC): “This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.”

Vendor name: Cyclops Vision Corporation

Date Certified: 06/06/2014

Product Version: Version 4

Criteria Certified: Meaningful use Stage 2 (2014 Edition)

Certification ID Number: 06062014-2343-8

Additional software relied upon to certify: New Crop, DataMotion, Health Vault

Clinical Quality Measures Certified: See below

Certification criteria which has been tested and certified: See below

Modules Tested

  • (a)(1) Computerized Provider Order Entry
  • (a)(2) Drug-Drug, Drug-Allergy Interaction
  • (a)(3) Demographics
  • (a)(4) Vital signs, BMI, and growth charts
  • (a)(5) Problem List
  • (a)(6) Medication List
  • (a)(7) Medication Allergy List
  • (a)(8) Clinical Decision Support
  • (a)(9) Electronic Notes
  • (a)(10) Drug-Formulary Checks
  • (a)(11) Smoking Status
  • (a)(12) Image Results
  • (a)(13) Family Health History
  • (a)(14) Patient List Creation
  • (a)(15) Patient-Specific Education Resources
  • (b)(1) Transitions of Care – receive
  • (b)(2) Transitions of Care – create
  • (b)(3) Electronic Prescribing
  • (b)(4) Clinical Information Reconciliation
  • (b)(5) Incorporate Laboratory Test results
  • (b)(7) Data Portability
  • (c)(1) Clinical Quality Measures capture
  • (c)(2) Clinical Quality Measures import
  • (d)(1) Authentication, access control
  • (d)(2) Auditable Events and Tamper-Resistance
  • (d)(3) Audit Report(s)
  • (d)(4) Amendment
  • (d)(5) Automatic log-off
  • (d)(6) Emergency access
  • (d)(7) End-User Device Encryption
  • (d)(8) Integrity
  • (e)(1) View, Download, and Transmit
  • (e)(2) Clinical Summary
  • (e)(3) Secure Messaging
  • (f)(1) Immunization Information
  • (f)(2) Transmission to Immunization Registries
  • (f)(3) Transmission to Public Health Agencies
  • (g)(2) Automated Measure Calculation
  • (g)(3) Safety-Enhanced Design
  • (g)(4) Quality Management System

Clinical Quality Measures Tested

  • CMS22 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
  • CMS50 Closing the referral loop: receipt of specialist report
  • CMS68 Documentation of Current Medications in the Medical Record
  • CMS69 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up
  • CMS122 Diabetes: Hemoglobin A1c Poor Control
  • CMS131 Diabetes: Eye Exam
  • CMS132 Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
  • CMS133 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
  • CMS138 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
  • CMS142 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
  • CMS143 Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
  • CMS148 Hemoglobin A1c Test for Pediatric Patients
  • CMS156 Use of High-Risk Medications in the Elderly
  • CMS165 Controlling High Blood Pressure
  • CMS167 Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy

Partners

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